StockData
Alvotech logo

Alvotech (ALVO) stock

ALVONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ALVOW
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 3/30
$4.37−0.04 (-0.79%)

Close on Nov 17, 2026Market cap $1.36BP/E 43.7Yield –

Alvotech operating margin

Operating margin is operating income as a percentage of revenue.

For fiscal 2025 it was 13.3%, against 14.2% the year before. The highest annual figure on record is 14.2% in fiscal 2024.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202513.3%−0.9
FY2024Dec 31, 202414.2%+402.3
FY2023Dec 31, 2023-388.1%+29.1
FY2022Dec 31, 2022-417.3%+223.1
FY2021Dec 31, 2021-640.3%−433.9
FY2020Dec 31, 2020-206.5%–

More Alvotech figures

See a number that looks wrong?